Yu-Sheng Chang

10PUBLICATIONS
28CO-AUTHORS
HaematologyRespiratory diseasesMolecular targetsSocial epidemiologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Hematological Indices as Biomarkers in Patients With Rheumatoid Arthritis but Normal ESR/CRP Receiving Biological/Targeted Synthetic DMARDs.

|Jun 05, 2026
Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis Using Electronic Health Records: Multicenter Cohort Study.

|Apr 01, 2026
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.

Yu-Hsiu Chen, Virginia Byers Kraus, Yu-Sheng Chang

|Dec 12, 2025
Systemic Lupus Erythematosus Severity Transitions and Related Impact on Health-Care Utilization and Costs.

Yu-Sheng Chang, Jui-Hung Kao, Wen-Nan Huang

|Mar 13, 2025
Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas.

Wei-Sheng Chen, Tzu-Min Lin, Yu-Sheng Chang

|Nov 29, 2021
Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study.

Chin-Fang Su, Chien-Chih Lai, Tzu-Hao Li

Pageof 2

Frequent Collaborators

4 joint publications

Chien-Chih Lai

2 joint publications

Chin-Fang Su

2 joint publications

Jui-Hung Kao

1 joint publications

Wei-Sheng Chen